2-[4-(2-DIPHENYLPHOSPHANYLNAPHTHALEN-1-YL)-QUINAZOLIN-2-YL]-2-METHYLPROPIONITRILE
Compound with spectra: 1 NMR
![2-[4-(2-DIPHENYLPHOSPHANYLNAPHTHALEN-1-YL)-QUINAZOLIN-2-YL]-2-METHYLPROPIONITRILE](/api/compound/C2KbpSH5F0U.png?ph=true&h=300&w=458 "2-[4-(2-DIPHENYLPHOSPHANYLNAPHTHALEN-1-YL)-QUINAZOLIN-2-YL]-2-METHYLPROPIONITRILE")
| SpectraBase Compound ID | C2KbpSH5F0U |
|---|---|
| InChI | InChI=1S/C34H26N3P/c1-34(2,23-35)33-36-30-20-12-11-19-28(30)31(37-33)29-22-21-24-13-9-10-18-27(24)32(29)38(25-14-5-3-6-15-25)26-16-7-4-8-17-26/h3-22H,1-2H3 |
| InChIKey | RFERLASHSBDATF-UHFFFAOYSA-N |
| Mol Weight | 507.6 g/mol |
| Molecular Formula | C34H26N3P |
| Exact Mass | 507.186435 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(R,S)-DIPHENYL-[1-(2-TERT.-BUTYL-QUINAZOLIN-4-YL)-(2-NAPHTHYL)]-PHOSPHINE
(R,S)-DIPHENYL-[1-(2-PHENYLMETHYLQUINAZOLIN-4-YL)-(2-NAPHTHYL)]-PHOSPHINE
(R,S)-Diphenyl[1-(2-isopropylquinazolin-4-yl)(2-naphthyl)]phosphine
3(2H)-Pyridazinone, 6-(8,9,10,11-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-2-yl)-
3,3-Difluoro-1,9-diphenyl-2,3-dihydro-1H-cyclopenta[b]quinoline
(S)-CAMPHOR-(4RS,5RS)-5-FLUORO-4-HYDROXY-5-HEPTAFLUOROPROPYL-4-TRIFLUOROMETHYL-4,5-DIHYDROTHIAZOL-2-YLHYDRAZONE_HYDRATE
MYRICETIN-3-O-(6''-ACETYL)-BETA-D-GALACTOPYRANOSIDE
MYRICETIN-3-O-ALPHA-L-3'',5''-DIACETYLARABINOFURANOSIDE
7,8-DIHYDRO-3,4,10,11,12-PENTAMETHOXYDIBENZ-[C,E]-AZOCIN-5(6H)-ONE
(1R*,5S*,6R*,9R*,12S*)-6,10,10-Trimethyl-11-oxatricyclo[7.2.1.0(1,6)]dodecane-5,9,12-triol
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Application of Quinazoline−Oxazoline-Containing (Quinazox) Ligands | Organic Letters | 2006 |